HIV & AIDS Information :: News

aidsmap hiv & aids news

RSS

Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect

New and experimental HIV treatments
Liz Highleyman | 06 March 2013
Cenicriviroc, which blocks both CCR5 and CCR2 receptors on immune cells, is effective against HIV, better tolerated than current antiretrovirals and has immunomodulatory activity that may reduce inflammation, according to a presentation yesterday ...
Small risk of neurological birth defects due to efavirenz confirmed in French cohort

Prevention of mother-to-child transmission
Keith Alcorn | 06 March 2013
A large French study has found an elevated risk of some birth defects in children born to women exposed to some antiretroviral drugs during the first trimester of pregnancy, French researchers reported ...
HIV treatment for children is safe and highly effective without laboratory monitoring in large African trial

Health monitoring in resource-limited settings
Keith Alcorn | 05 March 2013
Children did just as well on antiretroviral therapy without routine laboratory monitoring of CD4 cell counts or drug side-effects as those who received regular monitoring during four years of follow-up, researchers from Uganda ...
French studies report real-world data on use of telaprevir and boceprevir in people with HIV and hepatitis C co-infection

Hepatitis C treatment
Liz Highleyman | 05 March 2013
Adding boceprevir or telaprevir to interferon-based therapy showed promising indications of efficacy and acceptable safety for difficult-to-treat HIV/HCV co-infected prior non-responders in a pair of French studies presented yesterday at the 20th Conference on Retroviruses and ...
Very early antiretroviral treatment limits the size of HIV reservoir

The search for a cure
Keith Alcorn | 05 March 2013
Very early antiretroviral treatment may limit the size of the HIV reservoir in adults and children, according to studies presented on 4 March at the 20th Conference on Retroviruses and Opportunistic Infections (CROI) ...
Sofosbuvir/ledipasvir/ribavirin cures 100% of genotype 1 hepatitis C patients

New and experimental hepatitis C treatment
Liz Highleyman | 05 March 2013
An interferon-free regimen containing sofosbuvir (formerly GS-7997), ledipasvir (formerly GS-5885) and ribavirin produced a 12-week post-treatment sustained virological response (SVR12) rate of 100% for both treatment-naive hepatitis C patients and prior interferon non-responders, according ...
Consistent condom use in anal sex stops 70% of HIV infections, study finds, but intermittent use has no effect

Condoms and lubricant
Gus Cairns | 04 March 2013
An analysis by Dawn Smith of the US Centers for Disease Control (CDC) reported at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) on 4 March has provided the first ...
Monthly injectable drug offers 100% protection against HIV in monkeys – could be dosed every three months

PrEP
Gus Cairns | 04 March 2013
An injectable, long-lasting integrase inhibitor drug, when given to rhesus macaques exposed to a monkey-adapted version of HIV, completely protected them against the virus. This drug, an injectable version of GSK1265744 (GSK744), has ...
VOICE trial's disappointing result poses big questions for PrEP

PrEP
Gus Cairns | 04 March 2013
The failure of one of the largest trials yet conducted of HIV drug-based prevention methods poses questions for how to turn vaginal microbicides and oral pre-exposure prophylaxis (PrEP) into methods people can actually ...
Case report of a 'functional' HIV cure in a child

The search for a cure
Keith Alcorn | 03 March 2013
Researchers in the United States say that they have identified a case of a 'functional' HIV cure in a child infected with HIV who began antiretroviral treatment within days of birth. The ...

hiv & aids news selected from other sources

HIV and criminal law

Swiss police arrest "healer" accused of infecting 16 with HIV

Reuters | 18 March 2013

Swiss police have arrested a self-styled healer after he stopped attending a trial where he stands accused of infecting 16 people with HIV using acupuncture needles.
Drug-resistant TB

Global Drug Facility achieves price reduction for drug-resistant TB treatments

Stop TB Partnership | 18 March 2013

The Stop TB Partnership’s Global Drug Facility has reduced the price of several second-line drugs it supplies for the treatment of multidrug resistant tuberculosis (MDR-TB) by up to 26% compared to 2011 prices, resulting in a decrease in the overall cost of treatment.
Pharmaceutical industry

GlaxoSmithKline boss says new drugs can be cheaper

Reuters | 18 March 2013

The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to the chief executive of GlaxoSmithKline Plc.
Women

U.N. body agrees on women's rights policy, skirting sexual politics

Reuters | 17 March 2013

A U.N. policy-making body agreed upon a declaration Friday urging an end to violence against women and girls despite concerns from conservative Muslim countries and the Vatican about references to women's sexual and reproductive rights.
Telling people you have HIV

I'm Sorry My HIV Offends You

Huffington Post | 17 March 2013

It's easy to be an ass on mobile dating apps because you can hide behind a cell phone. It's also easy to get your feelings hurt if you don't quickly come to terms with the fact that guys online can be vicious.
Religion and faith

Pope Francis' View on Contraception Could Impact AIDS Work

ABC News | 15 March 2013

Catholic organizations around the world are still digesting how the selection of Jorge Bergoglio of Argentina, now Pope Francis , might impact their work, and that includes disease-prevention efforts.
HIV prevention policy

England: Sexual health improvement framework published

Department of Health | 15 March 2013

‘A Framework for Sexual Health Improvement in England’ sets out the government’s ambitions for improving sexual health. These are designed to be used by local organisations when they are looking at how best to provide sexual health services in their area.
History of HIV and AIDS

NEW YORK: Historical Society Exhibition to Explore the Early Days of AIDS

CDC National Prevention Information Network | 15 March 2013

This summer, the New York Historical Society will mount an exhibition titled “AIDS in New York: The First Five Years,” which will focus on the early years of AIDS in New York City. Comprised of diaries, ephemera such as clinician’s notes and photographs, and both audio and video clips, the exhibition will examine the impact of the disease from the first days of rumors of a “gay plague” in 1981 through 1986.
The search for a cure

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

PLoS Pathogens | 15 March 2013

Our results show that early and prolonged cART may allow some individuals with a rather unfavorable background to achieve long-term infection control and may have important implications in the search for a functional HIV cure.
Religion and faith

Over 2,000 People Have Stopped HIV Meds for Prayer in Ghana

Poz magazine news | 15 March 2013

A total of 2,248 people with HIV/AIDS on antiretroviral treatment in Ghana have stopped taking their medications to seek help at prayer camps and from traditional healers.

Latest news

aidsmap hiv & aids news

RSS

Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect

Small risk of neurological birth defects due to efavirenz confirmed in French cohort

HIV treatment for children is safe and highly effective without laboratory monitoring in large African trial

French studies report real-world data on use of telaprevir and boceprevir in people with HIV and hepatitis C co-infection

Very early antiretroviral treatment limits the size of HIV reservoir

Sofosbuvir/ledipasvir/ribavirin cures 100% of genotype 1 hepatitis C patients

Consistent condom use in anal sex stops 70% of HIV infections, study finds, but intermittent use has no effect

Monthly injectable drug offers 100% protection against HIV in monkeys – could be dosed every three months

VOICE trial's disappointing result poses big questions for PrEP

Case report of a 'functional' HIV cure in a child

More

hiv & aids news selected from other sources

Swiss police arrest "healer" accused of infecting 16 with HIV

Global Drug Facility achieves price reduction for drug-resistant TB treatments

GlaxoSmithKline boss says new drugs can be cheaper

U.N. body agrees on women's rights policy, skirting sexual politics

I'm Sorry My HIV Offends You

Pope Francis' View on Contraception Could Impact AIDS Work

England: Sexual health improvement framework published

NEW YORK: Historical Society Exhibition to Explore the Early Days of AIDS

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

Over 2,000 People Have Stopped HIV Meds for Prayer in Ghana

Conference news

HIV treatment update

aidsmap news iPhone app

HIV drug prescribing

aidsmap news feeds

Email updates

Latest news

aidsmap hiv & aids news

hiv & aids news selected from other sources

aidsmap news feeds

Email updates

Share/bookmark this page